1. Adams B, Fataar A, Nizami M (1996) Technetium-99m-sestamibi uptake in myeloma. J Nucl Med 37:1001–1002
2. Alexandrakis M, Kyriakou D, Passam F, Koukouraki S, Karkavitsas N (2001) Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate. Ann Hematol 80:349–353
3. Biassoni L, Tirovola E, Kaleva N, Kouykin V, Britton K (1995) Myeloma imaging with Tc99m-MIBI. Eur J Nucl Med 22:856
4. Catalano L, Pace L, Califano C, Pinto A, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B (1999) Detection of myeloma lesions by technetium-99m-sestaMIBI scintigraphy. Haematologica 84:119–124
5. Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semenzato G, Pizzolo G, Menestrina F (1999) CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol 12:1101–1106